Joe Basha's PerfWeb #98—Day 2— Understanding ECLS: Navigating Its Adverse Effects— Perfusion

The PerfWeb Podcast - Ein Podcast von MediWeb

Kategorien:

PerfWeb 98 continues its educational journey into Day 2, focusing on the pivotal aspects of Extracorporeal Life Support (ECLS) and its adverse effects. Scheduled for Tuesday, March 19, 2024, this session is a crucial convergence for perfusionists, offering deep dives into the complexities and challenges associated with ECLS treatments. Endorsed with 1.2 Category 1 CEUs by the American Board of Cardiovascular Perfusion (ABCP), this seminar underscores the commitment to providing cutting-edge education and fostering a deeper understanding of critical care in perfusion practices. Event Overview Date: Tuesday, March 19, 2024 Time: 1700-1900 PerfWeb 98—Day 2 is singularly designed to enrich the knowledge base of perfusionists with a comprehensive exploration of ECLS. This session aims to equip professionals with the insights needed to navigate the adverse effects of ECLS, enhancing patient care and outcomes. The seminar is an essential platform for those in the field seeking to bolster their expertise, stay updated with the latest research, and engage in meaningful discussions on overcoming ECLS challenges. Session Details Adverse Effects of ECLS Faculty: V. Carlyle, RN, BSN-CCRN The session will be led by V. Carlyle, RN, BSN-CCRN, a distinguished figure in the field of critical care nursing with extensive experience in ECLS. Carlyle’s presentation is set to cover the gamut of potential adverse effects associated with ECLS, including but not limited to thrombosis, bleeding, infection, and neurological complications. The session aims to not only outline these challenges but also to delve into preventive strategies, management techniques, and the latest research findings that can help mitigate these adverse effects. Participants will have the opportunity to engage in an interactive discussion, sharing experiences, strategies, and questions related to ECLS complications. This collaborative environment is designed to foster a community of learning and support among perfusionists and critical care professionals. CEU Accreditation This session has received the approval of 1.2 Category 1 CEUs by the ABCP, validating its educational merit and relevance to the perfusion community. This accreditation ensures that participants are recognized for their dedication to advancing their knowledge and skills, contributing to their professional development and the quality of care provided to patients. Why Attend? Expert Insights: Gain valuable knowledge from an experienced professional in the field of critical care and ECLS, enhancing your understanding of the adverse effects and management strategies. CEU Accreditation: Earn 1.2 Category 1 CEUs approved by the ABCP, supporting your professional development and maintaining your certification. Collaborative Learning: Benefit from the shared experiences and strategies of peers, enriching your practice and problem-solving skills. Critical Updates: Stay informed on the latest research and developments in ECLS, ensuring your practice is aligned with current standards and best practices. Registration and Participation Advance registration is encouraged for those planning to attend PerfWeb 98—Day 2. Complete details on how to register, including any associated fees, can be found on the official event website. Participants will also have access to post-event session recordings, offering flexibility in engaging with the material at their convenience. PerfWeb 98—Day 2 is an indispensable opportunity for perfusionists to deepen their understanding of ECLS, confront its adverse effects, and explore innovative solutions for enhancing patient outcomes. This seminar promises to be a valuable addition to the educational calendar of any perfusionist committed to excellence in their field. Join us on March 19, 2024, to partake in an educational experience that will shape the future of perfusion practices and patient care across North America.

Visit the podcast's native language site